Reduction of the total IgE Level by omalizumab in children and adolescents

J Asthma. 2009 Feb;46(1):102-3. doi: 10.1080/02770900802513015.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Anti-Asthmatic Agents / administration & dosage
  • Anti-Asthmatic Agents / therapeutic use
  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Asthma / blood*
  • Asthma / drug therapy*
  • Child
  • Clinical Trials as Topic
  • Drug Monitoring
  • Humans
  • Immunoglobulin E / blood*
  • Immunoglobulin E / immunology
  • Omalizumab

Substances

  • Anti-Asthmatic Agents
  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Omalizumab
  • Immunoglobulin E